PropertyValue
?:abstract
  • AIM: To evaluate the clinical efficacy and fusion characteristics of allografts in spinal tuberculosis (TB). MATERIAL AND METHODS: The research reviewed 1196 patients with spinal tuberculosis who received treatment at six hospitals from January 2000 to January 2016. A total of 623 patients who had spinal tuberculosis were included in the study. All patients underwent debridement, decompression, allograft bone grafting, and instrumentation. Postoperative treatment consisted of a combination of anti-TB drug treatment for 18 months and brace fixed braking for 3-9 months. Clinical outcome, laboratory indexes, and radiological results were analysed. RESULTS: The average follow-up time was 34.1 months (12-60 months). Pain was relieved postoperatively in all cases, and 87.8% of patients were painless at the final follow-up. The erythrocyte sedimentation rate (ESR) significantly decreased and returned to normal at the final follow-up. The fusion rate of allografts was 30.2% and 98.4% at the 9- and 12-month follow-ups, respectively. At the final follow-up, the fusion rate was 100%. CONCLUSION: The application of allografts in the surgical management of spinal tuberculosis is safe and effective. Allografts can replace autografts in surgeries for spinal tuberculosis.
is ?:annotates of
?:creator
?:journal
  • Turkish_neurosurgery
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • The analysis of safety and effectiveness of using allografts in the treatment of spinal tuberculosis-A multicentre retrospective study
?:type
?:who_covidence_id
  • #32530474
?:year
  • 2019

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/ke92rb0e>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/ke92rb0e>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all